(1)
Clinical Outcome of Lenvatinib Versus Sorafenib in the Management of Advanced Hepatocellular Carcinoma: a Comparative Study in Dhaka, Bangladesh. Sir Salimullah Med. Coll. J. 2025, 32 (2), 59-64. https://doi.org/10.3329/ssmcj.v32i2.84524.